Hearing Loss, Sudden Clinical Trial
Official title:
Prospective Study of Sudden Deafness
To study the effective treatment of sudden deafness by giving prednisone, hyperbaric oxygen and somatosensory stimulation to sudden deafness patients.
60 cases of sudden deafness within 2 months of 14-80 years old were randomly divided into two groups. They underwent hearing tests, magnetic resonance imaging of the head, and routine hospital admissions. One group was given prednisone for 1 mg / kg body weight × 7 days + somatosensory stimulation × 30 days, the other group was given prednisone for 1 mg / kg body weight × 7 days + hyperbaric oxygen × 15 days, and repeated electrical audiometry every week. One month and three months after the experiment, repeated audiometry. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02414152 -
Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss
|
Phase 1/Phase 2 | |
| Completed |
NCT05052944 -
Single-sided Deafness and Cochlear Implantation
|
||
| Not yet recruiting |
NCT05786378 -
Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04766853 -
Verification of the Efficacy/Safety of the Intratympanic Drug Delivery for Hearing Loss
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05474963 -
Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital
|
||
| Not yet recruiting |
NCT06437054 -
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06365775 -
Multi-omics Characteristics and Prognosis of Idiopathic Sudden Sensorineural Hearing Loss
|
||
| Recruiting |
NCT05455398 -
Establishment of a Trans-round Window Inner Ear Continuous Drug Delivery System for the Treatment of Severe-to-profound Sudden Sensorineural Hearing Loss
|
N/A |